# POINT Biopharma USA Inc. – FDA Inspection, Jun 7, 2024

Source: https://www.keypedia.com/records/fda_inspections/point-biopharma-usa-inc/efc7aa6b-4ef1-40c9-a20c-e4006bec2eb0
Source feed: FDA_Inspections

> FDA inspection 1240823 of POINT Biopharma USA Inc., June 07, 2024. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240823
- Company Name: POINT Biopharma USA Inc.
- Inspection Date: 2024-06-07
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Detroit District Office
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-m-schuckmann/69dd0728-6b5d-41e7-834c-416e25a977dc)
- [FDA Associated Person](https://www.keypedia.com/people/muna-algharibeh/0f0dbd13-b36a-408d-8e42-4625f8de905d)

Company: https://www.keypedia.com/companies/point-biopharma-usa-inc/f4a8cb71-7a5c-4407-a6c8-6765aacfb8da

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03